Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 8/20 | 0.44 |
| ▸ | CXCR3 | P49682 | 1/20 | 0.40 |
| ▸ | CACNA1H | O95180 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | CHIA | Q9BZP6 | 1/20 | 0.38 |
| ▸ | ME2 | P23368 | 2/20 | 0.38 |
| ▸ | ME1 | P48163 | 2/20 | 0.38 |
| ▸ | ME3 | Q16798 | 2/20 | 0.38 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.38 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.38 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.37 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3060784 | 0.92 | AOC3 (0.41) | HRH3CXCR3KDM4EMEN1ALDH1A1 | |
| SCHEMBL3063912 | 0.90 | CACNA1H (0.46) | CACNA1HKDM4EALDH1A1ME2ME1 | |
| SCHEMBL3064722 | 0.89 | AOC3 (0.45) | CACNA1HKDM4EALDH1A1ME2ME1 | |
| SCHEMBL8162530 | 0.85 | TRPV1 (0.44) | L3MBTL1KDM4EALDH1A1TDP1ME2 | |
| SCHEMBL3058884 | 0.85 | TRPV1 (0.44) | L3MBTL1KDM4EALDH1A1TDP1ME2 | |
| SCHEMBL3053852 | 0.84 | ME2 (0.43) | L3MBTL1KDM4EALDH1A1ME2ME1 | |
| SCHEMBL3064704 | 0.84 | AOC3 (0.47) | KDM4EMEN1ALDH1A1KMT2AME2 | |
| SCHEMBL3048291 | 0.83 | KCNH2 (0.45) | HRH3KDM4EALDH1A1TDP1 | |
| SCHEMBL3059061 | 0.83 | OPRM1 (0.45) | HRH3CACNA1HL3MBTL1KDM4EALDH1A1 | |
| SCHEMBL3057965 | 0.83 | AOC3 (0.49) | L3MBTL1KDM4EMEN1ALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100267697-A1 | ION CHANNEL MODULATORS | WYETH (US) | 2010-10-21 | — | — | US | claimed |
| EP-2099754-A1 | ION CHANNEL MODULATORS | Wyeth a Corporation of the State of Delaware (US) | 2009-09-16 | — | — | EP | claimed |
| WO-2008073929-A1 | ION CHANNEL MODULATORS | WYETH (US) | 2008-06-19 | — | — | WO | claimed |
| US-20100267697-A1 | ION CHANNEL MODULATORS | WYETH (US) | 2010-10-21 | — | — | US | disclosed |
| US-20100267697-A1 | ION CHANNEL MODULATORS | WYETH (US) | 2010-10-21 | — | — | US | disclosed |
| US-20100267697-A1 | ION CHANNEL MODULATORS | WYETH (US) | 2010-10-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100267697-A1 | ION CHANNEL MODULATORS | CACNA1E, CACNA1A, CACNA1S | HRH3 680/4885CXCR3 3555/4885CACNA1H 13/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.